These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2565402)

  • 1. Synthesis and dopaminergic activity of 2-substituted octahydrobenzo[f]quinolines.
    Craig JC; Torkelson SM; Findell PR; Weiner RI
    J Med Chem; 1989 May; 32(5):961-8. PubMed ID: 2565402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
    Findell PR; Torkelson SM; Craig JC; Weiner RI
    Mol Pharmacol; 1988 Jan; 33(1):78-83. PubMed ID: 3336350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the preferred rotameric conformation for dopamine agonist action: an illusory quest.
    Costall B; Lim SK; Naylor RJ; Cannon JG
    J Pharm Pharmacol; 1982 Apr; 34(4):246-54. PubMed ID: 6124599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
    Bach NJ; Kornfeld EC; Clemens JA; Smalstig EB
    J Med Chem; 1980 Jul; 23(7):812-4. PubMed ID: 7190615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine.
    Nordmann R; Petcher TJ
    J Med Chem; 1985 Mar; 28(3):367-75. PubMed ID: 3973904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis- and trans-N-benzyl-octahydrobenzo[g]quinolines. Adrenergic and dopaminergic activity studies.
    Thermos K; Froudakis GE; Tagmatarchis N; Katerinopoulos HE
    Bioorg Med Chem Lett; 2001 Apr; 11(7):883-6. PubMed ID: 11294383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
    Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ
    Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
    Tagmatarchis N; Thermos K; Katerinopoulos HE
    J Med Chem; 1998 Oct; 41(21):4165-70. PubMed ID: 9767652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.
    Clark AH; McCorvy JD; Conley JM; Williams WK; Bekkam M; Watts VJ; Nichols DE
    Bioorg Med Chem; 2012 Nov; 20(21):6366-74. PubMed ID: 23018094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.
    Cannon JG; Hatheway GJ
    J Med Chem; 1976 Aug; 19(8):987-93. PubMed ID: 184283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophores.
    Froimowitz M; Deng Y; Jacob JN; Li N; Cody V
    Drug Des Discov; 1995 Aug; 13(1):73-81. PubMed ID: 8882902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
    Cannon JG; Amoo VE; Long JP; Bhatnagar RK; Flynn JR
    J Med Chem; 1986 Dec; 29(12):2529-34. PubMed ID: 3783613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.
    Cannon JG; Lee T; Goldman HD; Long JP; Flynn JR; Verimer T; Costall B; Naylor RJ
    J Med Chem; 1980 Jan; 23(1):1-5. PubMed ID: 7188974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.
    Cannon JG; Suarez-Gutierrez C; Lee T; Long JP; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Apr; 22(4):341-7. PubMed ID: 571020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
    Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
    J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
    Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
    J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bi- and tricyclic ergoline analogs with dopaminergic actions].
    Gmeiner P
    Pharm Unserer Zeit; 1994 Jun; 23(3):169-73. PubMed ID: 7913751
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
    McQuaid LA; Latz JE; Clemens JA; Fuller RW; Wong DT; Mason NR
    J Med Chem; 1989 Oct; 32(10):2388-96. PubMed ID: 2571732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.